June 25, 2025
Digital Framework Improves Lung Cancer Screening
Clinical cancer informatics research applying computational methods or digital health technologies to improve cancer care and patient outcomes.
Journal of Clinical Oncology
Research News
Explore our curated selection of the latest breakthroughs in lung cancer research.
June 25, 2025
Clinical cancer informatics research applying computational methods or digital health technologies to improve cancer care and patient outcomes.
Journal of Clinical Oncology
June 17, 2025
Researchers repurposed MDM2 inhibitor RG7388 as a potential targeted therapy for treating TP53-mutant non-small cell lung cancer patients.
Nature
June 4, 2025
Research develops hypoxic gene expression signatures to predict which muscle-invasive bladder cancer patients will respond to hypoxia-modifying therapies.
Journal of Clinical Oncology
May 5, 2025
A major Australian-Canadian lung cancer screening study found that 73% of high-risk participants had incidental findings during baseline CT scans, with 10% requiring clinical follow-up, highlighting significant inconsistencies in how these findings are reported to doctors and raising important questions about standardization as Australia prepares to launch its national screening program in 2025.
MJA
April 16, 2025
Researchers developed RARE-seq, an ultrasensitive blood test detecting cell-free RNA that identifies early-stage lung cancer and monitors treatment resistance.
Nature
April 11, 2025
Chest CT scans used for lung cancer screening can do more than just find early lung cancer. These scans can also detect heart problems and early emphysema, offering a three-in-one health check for people at risk.
ScienceDirect
March 7, 2025
Early detection of incidental lung nodules can lead to timely treatment and improved survival rates for lung cancer patients.
Managed Healthcare Executive
February 21, 2025
Final clinical trial results demonstrate selpercatinib’s safety and efficacy in treating RET fusion-positive non-small cell lung cancer patients.
Journal of Clinical Oncology
December 5, 2024
Scientists develop a groundbreaking urine test that detects “zombie” cell proteins, enabling early detection of lung cancer and potentially improving patient outcomes and prognosis.
The Guardian
October 13, 2023
UCLA researchers received a $6 million grant to refine a liquid biopsy blood test for early, accurate lung cancer detection and treatment guidance.
News Medical Life Sciences
October 4, 2023
Researchers developed a test detecting proteins in blood that indicate lung cancer spread, promising for early metastasis detection and treatment guidance.
News Medical Life Sciences
January 12, 2022
Rare EGFR exon insertions in lung cancer allow targeted therapies, but resistance develops; new drugs help.
Verywell Health
Learn more about:
LCFA prioritizes providing reliable information about new diagnostics, treatments, and prevention strategies, including exciting FDA-approved personalized therapies based on individual tumor biomarkers. Human-reviewed, AI-created content is used to create some of the summaries for the articles listed.